Dr Rick Furman interviewed at IWCLL by Patient... - CLL Support

CLL Support

22,986 members39,473 posts

Dr Rick Furman interviewed at IWCLL by Patient Power

AussieNeil profile image
AussieNeilPartnerAdministrator
2 Replies

Another up beat interview from IWCLL that I found particularly interesting. Again, most of us will need to remain patient for many years before the future portrayed by Dr Furman hopefully becomes our reality...

"Dr. Richard Furman, a leading CLL clinician and researcher at Weill-Cornell Medical College, attended the International Workshop on CLL in Germany and came away with a firm resolve not to prescribe chemotherapy regimens for his patients. With new medicines nearing expected FDA approval, Dr. Furman explains how a leading treatment candidate, ibrutinib, works. He also discusses whether there is concern that some patients may develop resistance to the drug and its effectiveness."

patientpower.info/video/why...

Neil

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .
Read more about...
2 Replies

Thanks Nick. Light at the end of the tunnel, good to have an upbeat video.

jangreen profile image
jangreen

Hi this video access to world experts is what the internet is all about. Best wishes

Not what you're looking for?

You may also like...

COVID-19 Vaccinations & Testing Dr. Furman & LLS

We had a CLL Society Zoom session on vaccinations with Dr. Furman April 11. He discourages getting...

Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD

In this Patient Power video - Dr. Brown is very clear about the advantages of Zanubrutinib over...

ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB

Hi friends In my last blog post ( http://bkoffman.blogspot.com ), I have a short and interesting...

Treatment Tradeoffs. Very good Video. Debate: Is it appropriate to treat patients with CLL earlier in the era of novel agents? Dr. Furman

Published on Apr 23, 2017 In this presentation from the 2017 Great Debates & Updates in...

MUST READ for those on Ibrutinib/Imbruvica - concerning advice in pilot study on lower dosing - incl. danger of starting with a lower dose

I'm repeating in full, this very important advice posted by Dr Rick Furman in the CLL/SLL Groups.io...